AnDiConBio

Jiaxing, China · Founded 2018 · Privately Held (backing)

Developer of drugs designed for respiratory anti-infection. AnDiConBio is based in Jiaxing, China and was founded in 2018. It has raised $43.4 million.

Last price · $/share
—
Implied valuation
—
Total raised
$43.4M
Last round
—

Who backs AnDiConBio?

15 investors
InvestorType
Cowin CapitalVenture capital
GSR United CapitalVenture capital
HaiBang VenturesOther
Heda VenturesOther
Zhuzhou SAH Innovation & Entrepreneur InvestmentOther
Jiaxing Jiarui Investment ManagementOther
Jiaxing Science and Technology City High-tech Industrial InvestmentOther
Everest VC—
Hengdian Capital—
Huajin Investment—
+ 5 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

AnDiConBio investors

15 investors are on record for AnDiConBio, including Cowin Capital, GSR United Capital, HaiBang Ventures and Heda Ventures.

Free account
More of AnDiConBio with a free account
  • ·The complete investor list: 15 names
  • ·Watch AnDiConBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 15 firms already write checks for companies like AnDiConBio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View